Equities research analysts predict that Danaher Co. (NYSE:DHR) will post $1.36 earnings per share for the current fiscal quarter, Zacks Investment Research reports. Five analysts have provided estimates for Danaher’s earnings, with the lowest EPS estimate coming in at $1.30 and the highest estimate coming in at $1.44. Danaher reported earnings of $1.16 per share in the same quarter last year, which would suggest a positive year-over-year growth rate of 17.2%. The business is scheduled to announce its next quarterly earnings report on Thursday, October 22nd.
According to Zacks, analysts expect that Danaher will report full-year earnings of $5.47 per share for the current fiscal year, with EPS estimates ranging from $5.35 to $5.60. For the next financial year, analysts anticipate that the business will post earnings of $6.32 per share, with EPS estimates ranging from $5.99 to $6.69. Zacks Investment Research’s earnings per share calculations are an average based on a survey of sell-side research analysts that follow Danaher.
Danaher (NYSE:DHR) last issued its earnings results on Thursday, July 23rd. The conglomerate reported $1.44 EPS for the quarter, topping the consensus estimate of $1.09 by $0.35. Danaher had a net margin of 17.73% and a return on equity of 11.88%. The company had revenue of $5.30 billion for the quarter, compared to the consensus estimate of $5.01 billion. During the same period in the previous year, the firm earned $1.09 earnings per share. The firm’s revenue for the quarter was up 2.7% on a year-over-year basis.
A number of research analysts have issued reports on the stock. Wolfe Research raised shares of Danaher from a “peer perform” rating to an “outperform” rating and set a $195.00 price objective on the stock in a research report on Tuesday, June 16th. Citigroup boosted their price objective on shares of Danaher from $180.00 to $190.00 and gave the company a “buy” rating in a research report on Friday, May 8th. Stifel Nicolaus boosted their price objective on shares of Danaher from $170.00 to $210.00 and gave the company a “hold” rating in a research report on Friday, July 24th. Jefferies Financial Group boosted their price objective on shares of Danaher from $190.00 to $230.00 and gave the company a “buy” rating in a research report on Friday, July 24th. Finally, Credit Suisse Group boosted their price objective on shares of Danaher from $165.00 to $169.00 and gave the company an “outperform” rating in a research report on Thursday, May 21st. Two investment analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company’s stock. The stock presently has a consensus rating of “Buy” and a consensus price target of $197.73.
Danaher stock traded down $0.18 during mid-day trading on Friday, reaching $205.75. 36,917 shares of the company traded hands, compared to its average volume of 2,120,310. The company has a debt-to-equity ratio of 0.68, a current ratio of 2.20 and a quick ratio of 1.74. The firm’s 50 day moving average price is $194.59 and its 200 day moving average price is $165.99. The firm has a market capitalization of $147.33 billion, a price-to-earnings ratio of 44.09, a P/E/G ratio of 3.26 and a beta of 0.95. Danaher has a 52-week low of $119.60 and a 52-week high of $209.15.
In other news, Director Walter G. Lohr sold 11,014 shares of the stock in a transaction that occurred on Thursday, May 28th. The shares were sold at an average price of $165.61, for a total value of $1,824,028.54. Following the transaction, the director now owns 22,392 shares in the company, valued at approximately $3,708,339.12. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, CFO Matthew Mcgrew sold 7,457 shares of the stock in a transaction that occurred on Wednesday, July 29th. The stock was sold at an average price of $203.42, for a total transaction of $1,516,902.94. Following the completion of the transaction, the chief financial officer now owns 12,387 shares in the company, valued at approximately $2,519,763.54. The disclosure for this sale can be found here. Insiders have sold a total of 427,955 shares of company stock worth $82,882,475 in the last 90 days. Company insiders own 11.70% of the company’s stock.
Large investors have recently modified their holdings of the company. Lion Street Advisors LLC bought a new position in shares of Danaher in the 1st quarter worth approximately $25,000. Howe & Rusling Inc. lifted its stake in shares of Danaher by 81.4% in the 2nd quarter. Howe & Rusling Inc. now owns 156 shares of the conglomerate’s stock worth $28,000 after purchasing an additional 70 shares during the period. Manchester Financial Inc. lifted its stake in shares of Danaher by 50.0% in the 1st quarter. Manchester Financial Inc. now owns 228 shares of the conglomerate’s stock worth $32,000 after purchasing an additional 76 shares during the period. Semmax Financial Advisors Inc. bought a new position in shares of Danaher in the 2nd quarter worth approximately $35,000. Finally, Trustcore Financial Services LLC increased its holdings in Danaher by 36.9% in the 2nd quarter. Trustcore Financial Services LLC now owns 230 shares of the conglomerate’s stock worth $41,000 after acquiring an additional 62 shares in the last quarter. Hedge funds and other institutional investors own 77.67% of the company’s stock.
Danaher Company Profile
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments; Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; cellular analysis, lab automation, and centrifugation instruments; microscopes; and genomics consumables.
Read More: How is diluted EPS different from basic EPS?
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.